Nvt Gmbh
Clinical trials sponsored by Nvt Gmbh, explained in plain language.
-
New heart valve trial hopes to offer less invasive option for aortic stenosis patients
Disease control TerminatedThis study is testing a new device called the ALLEGRA Plus Transcatheter Heart Valve in 177 people with severe aortic stenosis or a failed surgical valve. The valve is implanted through a catheter, avoiding open-heart surgery. Researchers are checking how safe and effective it is…
Phase: NA • Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New heart valve device shows promise for High-Risk patients
Disease control OngoingThis study looks at how well the ALLEGRA TAVI system works in real-world patients with severe aortic valve disease who are at high risk for surgery. Researchers tracked 346 patients to see if the device improves survival and quality of life. The goal is to control the disease and…
Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC